{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:19:45Z","timestamp":1767140385896,"version":"build-2238731810"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T00:00:00Z","timestamp":1635811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T00:00:00Z","timestamp":1635811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DA039192"],"award-info":[{"award-number":["R01 DA039192"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 AG024832"],"award-info":[{"award-number":["P30 AG024832"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["1K01AG070329"],"award-info":[{"award-number":["1K01AG070329"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00228-021-03244-4","type":"journal-article","created":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T13:33:26Z","timestamp":1635860006000},"page":"489-496","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Trends and variation in benzodiazepine use in nursing homes in the USA"],"prefix":"10.1007","volume":"78","author":[{"given":"Ioannis","family":"Malagaris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hemalkumar B.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James S.","family":"Goodwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,2]]},"reference":[{"key":"3244_CR1","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1001\/archinternmed.2009.357","volume":"169","author":"JC Woolcott","year":"2009","unstructured":"Woolcott JC, Richardson KJ, Wiens MO et al (2009) Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 169:1952\u20131960. https:\/\/doi.org\/10.1001\/archinternmed.2009.357","journal-title":"Arch Intern Med"},{"key":"3244_CR2","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1176\/appi.ajp.158.6.892","volume":"158","author":"PS Wang","year":"2001","unstructured":"Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J (2001) Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry 158:892\u2013898. https:\/\/doi.org\/10.1176\/appi.ajp.158.6.892","journal-title":"Am J Psychiatry"},{"key":"3244_CR3","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/bf03262280","volume":"29","author":"C Tannenbaum","year":"2012","unstructured":"Tannenbaum C, Paquette A, Hilmer S, Holroyd-Leduc J, Carnahan R (2012) A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs. Drugs Aging 29:639\u2013658. https:\/\/doi.org\/10.1007\/bf03262280","journal-title":"Drugs Aging"},{"key":"3244_CR4","doi-asserted-by":"publisher","first-page":"e363","DOI":"10.4088\/JCP.16m10713","volume":"78","author":"DT Maust","year":"2017","unstructured":"Maust DT, Blow FC, Wiechers IR, Kales HC, Marcus SC (2017) National trends in antidepressant, benzodiazepine, and other sedative-hypnotic treatment of older adults in psychiatric and primary care. J Clin Psychiatry 78:e363\u2013e371. https:\/\/doi.org\/10.4088\/JCP.16m10713","journal-title":"J Clin Psychiatry"},{"issue":"23","key":"3244_CR5","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1001\/jama.1989.03430230088031","volume":"262","author":"WA Ray","year":"1989","unstructured":"Ray WA (1989) Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA 262(23):3303. https:\/\/doi.org\/10.1001\/jama.1989.03430230088031","journal-title":"JAMA"},{"key":"3244_CR6","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1001\/archinte.1997.00440350031003","volume":"157","author":"MH Beers","year":"1997","unstructured":"Beers MH (1997) Explicit criteria for determining potentially inappropriate medication use by the elderly. Arch Intern Med 157:1531. https:\/\/doi.org\/10.1001\/archinte.1997.00440350031003","journal-title":"Arch Intern Med"},{"key":"3244_CR7","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1001\/archinte.163.22.2716","volume":"163","author":"DM Fick","year":"2003","unstructured":"Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH (2003) Updating the Beers Criteria for potentially inappropriate medication use in older adults. Arch Intern Med 163:2716. https:\/\/doi.org\/10.1001\/archinte.163.22.2716","journal-title":"Arch Intern Med"},{"key":"3244_CR8","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1001\/archinte.164.14.1567","volume":"164","author":"AK Wagner","year":"2004","unstructured":"Wagner AK, Zhang F, Soumerai SB et al (2004) Benzodiazepine use and hip fractures in the elderly. Arch Intern Med 164:1567. https:\/\/doi.org\/10.1001\/archinte.164.14.1567","journal-title":"Arch Intern Med"},{"key":"3244_CR9","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/jgs.15767","volume":"67","author":"DM Fick","year":"2019","unstructured":"Fick DM, Semla TP, Steinman M et al (2019) American Geriatrics Society 2019 Updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc 67:674\u2013694. https:\/\/doi.org\/10.1111\/jgs.15767","journal-title":"J Am Geriatr Soc"},{"key":"3244_CR10","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1001\/jamainternmed.2020.0989","volume":"180","author":"K Bykov","year":"2020","unstructured":"Bykov K, He M, Gagne JJ (2020) Trends in utilization of prescribed controlled substances in US commercially insured adults, 2004\u20132019. JAMA Intern Med 180:1006. https:\/\/doi.org\/10.1001\/jamainternmed.2020.0989","journal-title":"JAMA Intern Med"},{"key":"3244_CR11","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1176\/ps.2008.59.10.1191","volume":"59","author":"H Chen","year":"2008","unstructured":"Chen H, Nwangwu A, Aparasu R, Essien E, Sun S, Lee K (2008) The impact of Medicare Part D on psychotropic utilization and financial burden for community-based seniors. Psychiatr Serv 59:1191\u20131197. https:\/\/doi.org\/10.1176\/ps.2008.59.10.1191","journal-title":"Psychiatr Serv"},{"key":"3244_CR12","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1111\/j.1532-5415.2012.04031.x","volume":"60","author":"MK Ong","year":"2012","unstructured":"Ong MK, Xu H, Zhang L, Azocar F, Ettner SL (2012) Effect of Medicare Part D benzodiazepine exclusion on psychotropic use in benzodiazepine users. J Am Geriatr Soc 60:1292\u20131297. https:\/\/doi.org\/10.1111\/j.1532-5415.2012.04031.x","journal-title":"J Am Geriatr Soc"},{"key":"3244_CR13","unstructured":"Centers for Medicare & Medicaid Services (CMS) (2012) Transition to Part D coverage of benzodiazepines and barbiturates beginning in 2013. CMS web page. 1927:21244. https:\/\/www.cms.gov\/Medicare\/Prescription-Drug-Coverage\/PrescriptionDrugCovContra\/Downloads\/BenzoandBarbituratesin2013.pdf\u00a0Access date October 29, 2021."},{"key":"3244_CR14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.7399","volume":"2","author":"SD Agarwal","year":"2019","unstructured":"Agarwal SD, Landon BE (2019) Patterns in outpatient benzodiazepine prescribing in the United States. JAMA Netw Open 2:e187399. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.7399","journal-title":"JAMA Netw Open"},{"key":"3244_CR15","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1001\/jamainternmed.2018.0379","volume":"178","author":"DT Maust","year":"2018","unstructured":"Maust DT, Kim HM, Chiang C, Kales HC (2018) Association of the Centers for Medicare & Medicaid Services\u2019 national partnership to improve dementia care with the use of antipsychotics and other psychotropics in long-term care in the United States from 2009 to 2014. JAMA Intern Med 178:640\u2013647. https:\/\/doi.org\/10.1001\/jamainternmed.2018.0379","journal-title":"JAMA Intern Med"},{"key":"3244_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jamda.2005.12.016","volume":"7","author":"MQ Vu","year":"2006","unstructured":"Vu MQ, Weintraub N, Rubenstein LZ (2006) Falls in the nursing home: are they preventable? J Am Med Dir Assoc 7:53\u201358. https:\/\/doi.org\/10.1016\/j.jamda.2005.12.016","journal-title":"J Am Med Dir Assoc"},{"key":"3244_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12877-017-0428-1","volume":"17","author":"H Cioltan","year":"2017","unstructured":"Cioltan H, Alshehri S, Howe C et al (2017) Variation in use of antipsychotic medications in nursing homes in the United States: a systematic review. BMC Geriatr 17:32. https:\/\/doi.org\/10.1186\/s12877-017-0428-1","journal-title":"BMC Geriatr"},{"key":"3244_CR18","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s12877-020-01745-y","volume":"20","author":"AF Fog","year":"2020","unstructured":"Fog AF, Mdala I, Engedal K, Straand J (2020) Variation between nursing homes in drug use and in drug-related problems. BMC Geriatr 20:336. https:\/\/doi.org\/10.1186\/s12877-020-01745-y","journal-title":"BMC Geriatr"},{"key":"3244_CR19","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1111\/jgs.16776","volume":"68","author":"I Malagaris","year":"2020","unstructured":"Malagaris I, Mehta HB, Li S, Goodwin JS (2020) Decrease of anticholinergic drug use in nursing home residents in the United States, 2009 to 2017. J Am Geriatr Soc 68:2797\u20132804. https:\/\/doi.org\/10.1111\/jgs.16776","journal-title":"J Am Geriatr Soc"},{"key":"3244_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-017-2318-9","volume":"17","author":"JS Goodwin","year":"2017","unstructured":"Goodwin JS, Li S, Zhou J, Graham JE, Karmarkar A, Ottenbacher K (2017) Comparison of methods to identify long term care nursing home residence with administrative data. BMC Health Serv Res 17:1\u20138. https:\/\/doi.org\/10.1186\/s12913-017-2318-9","journal-title":"BMC Health Serv Res"},{"key":"3244_CR21","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.jamda.2017.04.021","volume":"18","author":"B Downer","year":"2017","unstructured":"Downer B, Thomas KS, Mor V, Goodwin JS, Ottenbacher KJ (2017) Cognitive status of older adults on admission to a skilled nursing facility according to a hospital discharge diagnosis of dementia. J Am Med Dir Assoc 18:726\u2013728. https:\/\/doi.org\/10.1016\/j.jamda.2017.04.021","journal-title":"J Am Med Dir Assoc"},{"key":"3244_CR22","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1097\/MLR.0b013e31819432e5","volume":"47","author":"C Van Walraven","year":"2009","unstructured":"Van Walraven C, Austin PC, Jennings A, Quan H, Forster AJ (2009) A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care 47:626\u2013633. https:\/\/doi.org\/10.1097\/MLR.0b013e31819432e5","journal-title":"Med Care"},{"key":"3244_CR23","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1111\/jgs.13702","volume":"63","author":"MJ Samuel","year":"2015","unstructured":"Samuel MJ (2015) American Geriatrics Society 2015 updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 63:2227\u20132246. https:\/\/doi.org\/10.1111\/jgs.13702","journal-title":"J Am Geriatr Soc"},{"key":"3244_CR24","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1007\/s11606-013-2723-7","volume":"2","author":"S Singh","year":"2014","unstructured":"Singh S, Lin Y-L, Kuo Y-F, Nattinger AB, Goodwin JS (2014) Variation in the risk of readmission among hospitals: the relative contribution of patient, hospital and inpatient provider characteristics. J Gen Intern Med 2:572\u2013578. https:\/\/doi.org\/10.1007\/s11606-013-2723-7","journal-title":"J Gen Intern Med"},{"key":"3244_CR25","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12913-017-2152-0","volume":"17","author":"RJ Korda","year":"2017","unstructured":"Korda RJ, Du W, Day C, Page K, Macdonald PS, Banks E (2017) Variation in readmission and mortality following hospitalisation with a diagnosis of heart failure: prospective cohort study using linked data. BMC Health Serv Res 17:220. https:\/\/doi.org\/10.1186\/s12913-017-2152-0","journal-title":"BMC Health Serv Res"},{"key":"3244_CR26","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1186\/s12913-018-3761-y","volume":"18","author":"K Hekkert","year":"2018","unstructured":"Hekkert K, Kool RB, Rake E et al (2018) To what degree can variations in readmission rates be explained on the level of the hospital? A multilevel study using a large Dutch database. BMC Health Serv Res 18:999. https:\/\/doi.org\/10.1186\/s12913-018-3761-y","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"3244_CR27","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s40801-016-0080-7","volume":"3","author":"MK Mattos","year":"2016","unstructured":"Mattos MK, Sereika SM, Naples JG, Albert SM (2016) Differences in benzodiazepine receptor agonist use in rural and urban older adults. Drugs Real World Outcomes 3(3):289\u2013296. https:\/\/doi.org\/10.1007\/s40801-016-0080-7","journal-title":"Drugs Real World Outcomes"},{"key":"3244_CR28","unstructured":"Pottie K, Thompson W, Davies S, Grenier J, Sadowski CA, Welch V, Holbrook A, Boyd C, Swenson R, Ma A, Farrell B (2018) Deprescribing benzodiazepine receptor agonists: Evidence-based clinical practice guideline. Can Fam Physician. 64(5):339\u2013351. PMID: 29760253; PMCID: PMC5951648"}],"updated-by":[{"DOI":"10.1007\/s00228-022-03360-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T00:00:00Z","timestamp":1657929600000}}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-021-03244-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-021-03244-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-021-03244-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T22:02:27Z","timestamp":1657922547000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-021-03244-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,2]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["3244"],"URL":"https:\/\/doi.org\/10.1007\/s00228-021-03244-4","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,2]]},"assertion":[{"value":"28 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00228-022-03360-9","URL":"https:\/\/doi.org\/10.1007\/s00228-022-03360-9","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research study was conducted retrospectively from de-identified data. The UTMB Institutional Review Board approved this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"N\/A. The UTMB Institutional Review Board waived the requirement for consent to participate\/consent to publish because the data was de-identified prior to use.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate\/for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}